ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 133 filers reported holding ADMA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $671,608 | -3.0% | 187,600 | 0.0% | 0.00% | – |
Q2 2023 | $692,244 | +88.1% | 187,600 | +68.7% | 0.00% | – |
Q1 2023 | $368,072 | -14.7% | 111,200 | 0.0% | 0.00% | – |
Q4 2022 | $431,456 | +285.2% | 111,200 | +141.7% | 0.00% | – |
Q3 2022 | $112,000 | +124.0% | 46,000 | +82.5% | 0.00% | – |
Q2 2022 | $50,000 | -65.3% | 25,200 | -69.3% | 0.00% | – |
Q1 2021 | $144,000 | -10.6% | 82,000 | -0.8% | 0.00% | – |
Q4 2020 | $161,000 | -37.8% | 82,700 | -23.8% | 0.00% | – |
Q3 2020 | $259,000 | -52.2% | 108,500 | -41.3% | 0.00% | – |
Q2 2020 | $542,000 | +107.7% | 184,900 | +104.3% | 0.00% | – |
Q1 2020 | $261,000 | +177.7% | 90,500 | +283.5% | 0.00% | – |
Q4 2019 | $94,000 | -10.5% | 23,600 | 0.0% | 0.00% | – |
Q3 2019 | $105,000 | +15.4% | 23,600 | 0.0% | 0.00% | – |
Q2 2019 | $91,000 | – | 23,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |